ABBV-400
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ABBV-400, covering 2025-05-22 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma [Phase 2]